证券代码：688579 证券简称：山大地纬 公告编号：2023-041 山大地纬软件股份有限公司 第四届监事会第八次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、 监事会会议召开情况 山大地纬软件股份有限公司（以下简称"公司"）第四届监事会第八次会议 通知于 2023 年 10 月 27 日以专人送达方式发送公司全体监事。会议于 2023 年 10 月 30 日以现场表决的方式召开。 本次会议应出席监事 3 人，实际出席监事 3 人，会议由监事会主席王新军召 集并主持。本次会议的召集、召开符合《中华人民共和国公司法》等法律、法规 及《公司章程》的有关规定。 经审核，监事会认为公司 2023 年第三季度报告的编制和审议程序符合相关 法律法规及《公司章程》等内部规章制度的规定；公司 2023 年第三季度报告的 内容与格式符合相关规定，公允地反映了公司 2023 年第三季度的财务状况和经 营成果等事项；第三季度报告编制过程中，未发现公司参与第三季度报告编制和 审议的人员有违反保密规定的行为；监事会全体成员保证 ...

证券代码：688579 证券简称：山大地纬 公告编号：2023-044 山大地纬软件股份有限公司 关于召开 2023 年第一次临时股东大会的通知 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 一、 召开会议的基本情况 （一） 股东大会类型和届次 2023 年第一次临时股东大会 召开日期时间：2023 年 11 月 16 日 14 点 00 分 召开地点：山东省济南市章丘区文博路 1579 号 C 座会议室 股东大会召开日期：2023年11月16日 本次股东大会采用的网络投票系统：上海证券交易所股东大会网络投票 系统 （二） 股东大会召集人：董事会 （三） 投票方式：本次股东大会所采用的表决方式是现场投票和网络投票相结 合的方式 （四） 现场会议召开的日期、时间和地点 网投票平台的投票时间为股东大会召开当日的 9:15-15:00。 （六） 融资融券、转融通、约定购回业务账户和沪股通投资者的投票程序 涉及融资融券、转融通业务、约定购回业务相关账户以及沪股通投资者的投 票，应按照《上海证券交易所科创板上市公司自 ...

截至本公告披露日，孙明先生直接持有公司股份 6,594,048 股，持股比例为 1.65%。孙明先生将继续遵守《上海证券交易所科创板股票上市规则》《上市公 司股东、董监高减持股份的若干规定》《上海证券交易所上市公司股东及董事、 监事、高级管理人员减持股份实施细则》等相关规定及公司首次公开发行股票时 所作的相关承诺。 孙明先生担任公司职工代表监事期间，勤勉尽责，为公司的规范运作和健康 发展发挥了积极作用。在此，公司及公司监事会对孙明先生在任职期间为公司做 出的贡献表示衷心的感谢！ 山大地纬软件股份有限公司 关于监事辞职的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 山大地纬软件股份有限公司（以下简称"公司"）监事会于近日收到职工代 表监事孙明先生的书面辞职报告。因工作调整需要，孙明先生申请辞去职工代表 监事职务，其工作公司另有安排。 根据《中华人民共和国公司法》《公司章程》等有关规定，孙明先生辞去职 工代表监事职务不会导致公司监事会人数低于法定最低人数，亦不会导致职工代 表监事人数少于监事会成员的三分之一，不会影响公 ...

证券代码：688579 证券简称：山大地纬 公告编号：2023-039 山大地纬软件股份有限公司 关于关联交易进展的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示: 一、关联交易概述 （一）基本情况 公司参股的财金百廿学府（济南）创业投资合伙企业（有限合伙）（以下简 称"百廿基金"），基于业务推进缓慢，为保护合伙人利益，经合伙人一致同 意解散百廿基金并进行清算。 百廿基金设立以来未开展实质性经营活动，其解散清算对公司总体经营发展 不构成影响。 关于参与设立投资基金完成私募投资基金备案暨相关信息变更的公告》（公告编 号：2022-004）。 （二）决策与审批程序 本次关联交易事项已经公司 2021 年 5 月 26 日召开的第三届董事会第十四次 会议审议通过，关联董事已回避表决，独立董事已出具事前认可意见和明确同意 的独立意见。本事项无需提交公司股东大会审议。 二、关联交易进展情况 近日，公司收到参股基金百廿基金管理人山东省财金资本管理有限公司通知， 因合伙企业推进缓慢，自设立以来超过 12 个月尚未开展 ...

证券代码：688579 证券简称：山大地纬 公告编号：2023-038 山大地纬软件股份有限公司 关于张建军先生辞去高级副总裁、董事会秘书、执行委员会 委员职务的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 2023 年 9 月 23 日 山大地纬软件股份有限公司（以下简称"公司"）董事会于近日收到张建军 先生因个人原因申请辞去公司高级副总裁、董事会秘书、执行委员会委员职务的 报告。根据《公司法》《上海证券交易所科创板股票上市规则》等法律法规以及 《公司章程》的规定，张建军先生申请辞去公司高级副总裁、董事会秘书、执行 委员会委员职务的报告自送达董事会之日起生效。张建军先生已完成相关工作和 档案文件的交接，其辞去上述职务不会对公司正常的生产经营产生影响。 截至本公告披露日，张建军先生未持有公司股份。公司将按照《上海证券交 易所科创板上市公司自律监管指引第 1 号——规范运作》及《公司章程》等相关 规定尽快完成新任董事会秘书的选聘工作。在公司聘任新的董事会秘书之前，暂 由公司总裁史玉良先生代为履行董事会秘书职责。 公司 ...

证券代码：688579 证券简称：山大地纬 公告编号：2023-037 山大地纬软件股份有限公司 关于召开 2023 年半年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示: 投资者可于 2023 年 8 月 28 日(星期一)至 9 月 1 日(星期五)16:00 前登录上 证路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 ir@dareway.com.cn 进行提问。公司将在说明会上对投资者普遍关注的问题进行回答。 山大地纬软件股份有限公司（以下简称"公司"）已于 2023 年 7 月 31 日发 布公司 2023 年半年度报告，为便于广大投资者更全面深入地了解公司 2023 年半 年度经营成果、财务状况，公司计划于 2023 年 9 月 4 日上午 11:00-12:00 举行 2023 年半年度业绩说明会，就投资者关心的问题进行交流。 一、说明会类型 本次投资者说明会以网络互动方式召开，公司将针对 2023 年半年度的经营 成果及财务指标的具体情况与投资者进行互动交流和沟通，在 ...

Financial Performance - The company reported a significant increase in revenue for the first half of 2023, with total revenue reaching RMB 500 million, representing a year-on-year growth of 25%[16]. - The company's operating revenue for the first half of 2023 reached ¥201.81 million, a significant increase of 110.69% compared to ¥95.78 million in the same period last year[22]. - Net profit attributable to shareholders was ¥20.20 million, marking a 257.10% increase from a loss of ¥12.86 million in the previous year[24]. - The basic earnings per share rose to ¥0.0505, up from a loss of ¥0.0321 per share in the same period last year[23]. - The company achieved a revenue of 43 million, with a net profit of approximately 5.35 million, reflecting a growth of 24.64 million in the latest reporting period[72]. - The company reported a significant increase in revenue for the first half of 2023, achieving a total of 1.5 billion RMB, representing a 20% year-over-year growth[131]. - The company reported a total operating revenue for the first half of 2023 of ¥201,806,280.68, a significant increase of 110.9% compared to ¥95,784,009.45 in the same period of 2022[183]. - The net profit for the first half of 2023 was ¥20,201,874.24, compared to a net loss of ¥12,859,599.76 in the same period last year[185]. User Growth and Market Expansion - User data indicates that the active user base has expanded to 1.2 million, an increase of 15% compared to the previous year[16]. - The company has provided a positive outlook for the second half of 2023, projecting a revenue growth of 20% to 30%[16]. - The company is focusing on market expansion, targeting new regions in Southeast Asia, with an estimated investment of RMB 100 million for this initiative[16]. - The company is investing 200 million RMB in research and development for new technologies aimed at enhancing user experience[131]. - Market expansion plans include entering three new international markets by Q4 2023, targeting a 10% market share in each[132]. Research and Development - Research and development efforts have increased, with R&D expenditure rising to RMB 80 million, accounting for 16% of total revenue[16]. - The company’s R&D expenses for the current period were ¥49,936,028.47, a slight increase of 0.90% from the previous year[67]. - The company’s R&D efforts are focused on creating a smart healthcare ecosystem, leveraging AI/ML algorithms for data analysis and integration[63]. - The company has applied for 2 new patents and obtained 13, bringing the total to 42 invention patents and 440 software copyrights as of June 30, 2023[64]. - The company has established a three-tiered R&D system focused on advanced technology, software development, and operational services, ensuring a robust innovation pipeline[45]. Strategic Partnerships and Product Development - New product launches include the EasyAI platform, which aims to enhance AI development capabilities and is expected to contribute an additional RMB 50 million in revenue by year-end[16]. - A new strategic partnership has been established with a leading healthcare provider, expected to enhance service offerings and drive additional revenue of RMB 30 million annually[16]. - The company is focusing on the development of new products such as smart social security halls and user profiling, integrating technologies like virtual reality and AI[31]. - The company aims to enhance its product offerings in the healthcare sector with the launch of its new integrated hospital information system, DiVision[52]. Financial Health and Risks - The company's total assets decreased by 5.32% to ¥1.60 billion from ¥1.69 billion at the end of the previous year[22]. - The company has identified key risks, including regulatory changes and market competition, which could impact future performance[16]. - The company faces risks related to the national market strategy not meeting expectations, particularly in expanding outside Shandong province[96]. - There is a risk of slower-than-expected R&D progress, especially in keeping pace with rapid advancements in AI technologies like ChatGPT[97]. - Rising labor costs pose a challenge, as the company must manage personnel expenses effectively while expanding its business[99]. Investment and Capital Management - The company has invested ¥80,000,000.00 in the Shandong Jigaodiwei Huacheng Venture Capital Partnership, with a total of 7 projects funded as of the report date[117]. - The company plans to establish a special account for raised funds and sign a tripartite supervision agreement to ensure the funds are used specifically for designated projects[133]. - The company has committed to effective measures to enhance the efficiency of raised funds to mitigate the dilution of immediate returns after the public offering[133]. - The company has allocated RMB 10,000,000.00 to structured deposits with a projected annualized return of 2.52%[154]. Compliance and Governance - The company guarantees that its IPO application documents do not contain false records or misleading statements, and it will bear legal responsibility for the accuracy and completeness of the information[138]. - The company has established a profit distribution policy to ensure reasonable returns to shareholders while maintaining sustainable development[141]. - The company has no significant litigation or arbitration matters during the reporting period[143]. - The company has ensured that all related party transactions are conducted legally and at fair prices[141].

证券代码：688579 证券简称：山大地纬 公告编号：2023-021 山大地纬软件股份有限公司 山大地纬软件股份有限公司（以下简称"公司"）已于 2023 年 4 月 14 日发 布公司 2022 年度报告，于 2023 年 4 月 27 日发布公司 2023 年第一季度报告，为 便于广大投资者更全面深入地了解公司2022年年度及2023年第一季度经营成果、 财务状况，公司计划于 2023 年 5 月 25 日上午 10:00-11:30 举行 2022 年度暨 2023 年第一季度业绩说明会，就投资者关心的问题进行交流。 一、说明会类型 本次投资者说明会以视频结合网络互动方式召开，公司将针对 2022 年年度 及 2023年第一季度经营成果及财务指标的具体情况与投资者进行互动交流和沟 通，在信息披露允许的范围内就投资者普遍关注的问题进行回答。 二、说明会召开的时间、地点 关于召开 2022 年度暨 2023 年第一季度业绩说明会的 公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示: 会议召开时间：20 ...

Financial Performance - The company's operating revenue for Q1 2023 reached ¥101,965,867.56, representing a year-on-year increase of 217.09%[5] - Net profit attributable to shareholders was ¥14,150,249.80, marking a significant increase of 269.25% compared to the same period last year[5] - Basic and diluted earnings per share were both ¥0.0354, reflecting a growth of 269.38% year-on-year[6] - The company's net profit for Q1 2023 is not explicitly stated, but the increase in revenue and decrease in liabilities suggest a potential improvement in profitability[17] - The net profit for Q1 2023 was CNY 14,150,249.80, compared to a net loss of CNY 8,360,376.19 in Q1 2022, representing a significant turnaround[18] - Operating profit for Q1 2023 was CNY 15,749,691.13, an increase from a loss of CNY 9,269,724.96 in the same period last year[18] - The net profit for Q1 2023 was ¥16,870,922.75, compared to a net loss of ¥9,259,121.58 in Q1 2022, indicating a turnaround in profitability[27] Cash Flow and Liquidity - The net cash flow from operating activities was negative at -¥44,752,786.86, but improved by 12.48% compared to the previous year[6] - Cash flow from operating activities for Q1 2023 was negative at CNY -44,752,786.86, an improvement from CNY -51,137,101.07 in Q1 2022[20] - The company reported cash inflow from investment activities of CNY 222,882,193.00 in Q1 2023, a significant recovery from a cash outflow of CNY -36,909,166.73 in Q1 2022[21] - The company generated cash inflows from investment activities amounting to ¥240,473,132.89 in Q1 2023, a significant recovery compared to a cash outflow of ¥36,909,166.73 in Q1 2022[30] - Cash and cash equivalents as of March 31, 2023, amounted to RMB 330,819,976.84, up from RMB 153,581,546.70 at the end of 2022, reflecting a growth of approximately 115.5%[14] - The company reported a cash and cash equivalents balance of ¥313,466,953.47 at the end of Q1 2023, up from ¥388,069,421.53 at the end of Q1 2022[30] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,653,545,275.83, a decrease of 1.99% from the end of the previous year[6] - Total assets as of March 31, 2023, were RMB 1,653,545,275.83, down from RMB 1,687,169,158.93 at the end of 2022, a decrease of approximately 2.0%[16] - Total liabilities decreased to RMB 341,762,946.19 from RMB 390,385,872.89, a reduction of about 12.4%[16] - The total liabilities decreased from ¥386,085,671.10 in the previous year to ¥337,567,642.22, reflecting a reduction of about 12.6%[24] Research and Development - Research and development expenses totaled ¥30,764,318.46, which accounted for 30.17% of operating revenue, a decrease of 67.42 percentage points year-on-year[6] - Research and development expenses for Q1 2023 were RMB 24,876,396.77, slightly down from RMB 26,826,714.21 in Q1 2022, indicating a focus on cost management[17] - Research and development expenses for Q1 2023 were ¥23,627,576.72, slightly down from ¥25,118,218.50 in Q1 2022, showing a decrease of about 5.9%[26] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 8,645[11] - The largest shareholder, Shandong Shanda Capital Operation Co., Ltd., held 29.58% of the shares, totaling 118,342,400 shares[11] - The total equity attributable to shareholders as of March 31, 2023, was RMB 1,311,782,329.64, an increase from RMB 1,296,783,286.04 at the end of 2022, reflecting a growth of approximately 1.2%[16] - The total equity increased to ¥1,323,373,035.16 in Q1 2023 from ¥1,305,653,318.61 in Q1 2022, marking a growth of approximately 1.4%[24] Operating Costs and Expenses - Total operating costs for Q1 2023 were RMB 91,346,654.88, compared to RMB 56,820,461.02 in Q1 2022, indicating an increase of about 60.9%[17] - The total operating expenses for Q1 2023 were ¥85,426,084.93, compared to ¥69,006,953.36 in Q1 2022, reflecting an increase of about 23.9%[26] - The company reported a decrease in financial expenses, with a net financial income of ¥1,052,864.03 in Q1 2023, compared to a net expense of ¥2,038,225.47 in Q1 2022[26]

Financial Performance - The company's operating revenue for 2022 was ¥453,909,101.18, a decrease of 28.80% compared to ¥637,509,880.44 in 2021[23]. - The net profit attributable to shareholders for 2022 was ¥61,912,476.23, down 39.95% from ¥103,100,055.19 in 2021[23]. - The net cash flow from operating activities decreased by 58.16% to ¥39,924,845.63, compared to ¥95,414,884.45 in the previous year[25]. - The basic earnings per share for 2022 was ¥0.1548, a decline of 39.93% from ¥0.2577 in 2021[24]. - The total assets at the end of 2022 were ¥1,687,169,158.93, a decrease of 1.98% from ¥1,721,172,342.90 at the end of 2021[23]. - The weighted average return on net assets for 2022 was 4.82%, down 3.48 percentage points from 8.30% in 2021[24]. - The net profit after deducting non-recurring gains and losses was ¥45,923,636.33, a decrease of 46.27% from ¥85,474,815.72 in 2021[23]. - The decline in performance was primarily attributed to the macroeconomic environment affecting project execution and delivery schedules[25]. Research and Development - The R&D expenditure as a percentage of operating revenue increased to 28.50%, up 9.68 percentage points from 18.82% in 2021[24]. - Research and development expenses for 2022 amounted to CNY 12,936.63 million, reflecting a 7.82% increase from the previous year[37]. - The total R&D investment reached approximately ¥129.37 million, a 7.82% increase from the previous year, with R&D expenses accounting for 28.50% of operating revenue[85]. - The capitalized R&D investment increased by 25.91% year-over-year, indicating a strategic focus on long-term innovation[85]. - The company has received 9 new invention patents and 65 software copyrights during the reporting period, totaling 34 patents and 420 copyrights by December 31, 2022[81]. Corporate Governance - The company has confirmed that all board members attended the board meeting, ensuring accountability for the report's accuracy[5]. - The company has not reported any instances of more than half of the board members being unable to guarantee the report's authenticity[8]. - The company has maintained a governance structure that ensures independence from its controlling shareholders[180]. - The company held its annual general meeting on May 6, 2022, where all resolutions were approved without any objections[174]. - The company’s independent directors attended all board meetings and shareholder meetings without any absences[198]. Market and Business Strategy - The company plans to distribute a cash dividend of RMB 0.50 per 10 shares, totaling approximately RMB 20,000,500 (including tax) for the 2022 fiscal year[5]. - The company is focusing on expanding its market presence outside Shandong Province, with new orders signed in regions like the Yangtze River Delta and Pearl River Delta[124]. - The company aims to become a leading "AI + Blockchain" technology service provider in China, focusing on smart social security, smart healthcare, and intelligent electricity sectors[167]. - The company plans to enhance project delivery management to achieve rapid growth in operating performance, with historical highs in unconfirmed orders and gross profit at the end of the reporting period[168]. - The company is exploring potential acquisitions to enhance its service offerings, with a budget of RMB 200 million allocated for this purpose[190]. Technological Advancements - The company launched the EasyAI platform and a low-code platform to support cloud-native application development, enhancing its technological capabilities[36]. - The company is focusing on cloud computing, DevOps, and low-code platforms as new software service models, which are essential for optimizing resource allocation and enhancing software delivery efficiency[71]. - The company is committed to continuous innovation in blockchain and data element solutions, addressing various digital application scenarios and enhancing its market presence[76]. - The company has achieved significant advancements in artificial intelligence applications in the healthcare sector, enhancing patient experience and satisfaction through intelligent diagnosis and personalized treatment[70]. - The company has developed a digital asset public service platform based on blockchain technology, aimed at improving competitiveness and driving blockchain industry development[92]. Financial Risks and Management - The company faces risks related to the rapid technological upgrades in the software and information technology service industry, particularly with the rise of AI technologies like ChatGPT[122]. - The company's accounts receivable and contract assets totaled 350.06 million yuan, indicating potential liquidity risks if accounts receivable management is not handled properly[130]. - The company anticipates potential adverse impacts on its operating performance and profit levels if it fails to maintain its status as a high-tech enterprise or if favorable tax policies change[132]. - The company reported a significant decrease of 83.84% in payable taxes, totaling 2,873,988.47 RMB, due to tax payments made during the period[156]. - The company has a low debt-to-asset ratio, indicating a stable financial foundation despite facing competition from larger firms in the industry[125]. Future Outlook - The company reported a total revenue of RMB 1.2 billion for the fiscal year 2022, representing a year-over-year growth of 15%[190]. - The company has set a revenue guidance of RMB 1.5 billion for the next fiscal year, projecting a growth rate of 25%[190]. - New product launches are expected to contribute an additional RMB 300 million in revenue, with a focus on innovative software solutions[190]. - The company is investing RMB 100 million in R&D for new technologies aimed at enhancing user experience and operational efficiency[190]. - Future guidance indicates a positive outlook with expectations of continued revenue growth in the upcoming fiscal year[184].